Softwr

Healthcare · head to head

Annalise.ai vs Nookal

Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
Full reviewWebsite
Nookal logo

Nookal

Healthcare

Australian allied health practice management priced per practitioner with usage charges on top

From
49/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Nookal the features most multi-practitioner clinics need, including advanced reporting, custom forms and automated recalls, are held back to the Professional tier, so the AUD 49 entry price is not a realistic budget for anything beyond a solo practice.
  • They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Nookal covers Per practitioner pricing.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Annalise.ai and Nookal actually diverge.

Attributes where Annalise.ai and Nookal differ
AttributeAnnalise.aiNookal
Starting priceOn request49/month
Pricing modelquotePer user per month
PlatformsWeb, Cloud, On-premiseWeb, iOS, Android

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

Only in Nookal

  • Per practitioner pricing
  • Clinical notes
  • Online booking
  • Automated recalls
  • KPI dashboards
  • Claiming
  • Patient portal
  • AI and voice

What people use each for

The jobs each tool is most often brought in to do.

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Nookal
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Nookal
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Nookal
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Nookal

Nookal

  • A three to ten practitioner physiotherapy clinic in Australia that wants Medicare claiming and published pricing rather than a quote processnot Annalise.ai
  • A New Zealand practice that needs ACC claim submission integrated with its clinical notes and billingnot Annalise.ai
  • A chiropractic group opening a second location that wants shared patient records and one reporting view across sitesnot Annalise.ai
  • A UK or Irish allied health clinic that wants an Australian-style clinical workflow with GBP or EUR billingnot Annalise.ai

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Nookal

  • The features most multi-practitioner clinics need, including advanced reporting, custom forms and automated recalls, are held back to the Professional tier, so the AUD 49 entry price is not a realistic budget for anything beyond a solo practice.
  • Add-ons stack quickly: AI and voice at about USD 25 per active licence, the patient portal from USD 10 per location and secure messaging from USD 1.50 per user can push a seat close to double its list price.
  • Pricing is not a simple currency conversion, with the USD Essentials tier at 65 and Professional at 89 against AUD 49 and 59, so overseas clinics pay a meaningful premium for the same software.
  • Messaging and claiming are metered per SMS and per claim, so a clinic that leans on reminders to control no-shows finds a variable line item that grows with appointment volume and is easy to underestimate at purchase.
  • Single sign-on is quoted rather than listed and sits with the Enterprise tier, which puts basic identity governance out of reach for mid-sized groups that would otherwise stay on Professional.

Pricing, plan by plan

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Nookal

49/month
  • Essentials$49/month
    • Per practitioner per month
    • Appointments, patient records and invoicing
    • Online booking
  • Professional$59/month
    • Per practitioner per month
    • Advanced reporting and KPI dashboards
    • Custom forms
  • Enterprise$undefined/month
    • Quoted pricing
    • Multi-account management
    • Dedicated support

Which should you pick?

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.
Annalise.ai review

Choose Nookal if

  • You need per practitioner pricing.
  • You work on Web, iOS, Android.
  • You also want clinical notes.
Nookal review

Questions people ask

Is Annalise.ai or Nookal better?
Neither clearly leads. Annalise.ai starts at On request and Nookal at 49/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Annalise.ai or Nookal?
Annalise.ai starts at On request and Nookal at 49/month.
Does Annalise.ai or Nookal run on more platforms?
Annalise.ai runs on Web, Cloud, On-premise. Nookal runs on Web, iOS, Android.
What is Annalise.ai best used for?
Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Nookal is typically brought in for.
What can Annalise.ai do that Nookal cannot?
Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Nookal covers Per practitioner pricing, Clinical notes, Online booking, Automated recalls.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Nookal: How much does Nookal cost per practitioner?

Essentials is AUD 49 per practitioner per month and Professional is AUD 59, with published equivalents of GBP 29 and 39, EUR 65 and 89, and USD 65 and 89. Enterprise is quoted.

Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Nookal: What is not included in the subscription?

SMS from about 7 cents per message, Medicare claims from about 10 cents, ACC claims at about 12 cents, the patient portal, secure messaging, AI and voice, and single sign-on are all charged separately.

Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Nookal: Is there a contract?

No lock-in contract, and the free trial does not require a credit card.

Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Nookal: Which countries does the claiming work in?

Medicare claiming is Australian and ACC claiming is New Zealand. Elsewhere the software works but you invoice and reconcile manually.

Share

Related pages

More on Annalise.ai

More on Nookal

Keep looking

Other head to heads